Completed PHASE3 INTERVENTIONAL 2-arm NCT01439724

Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients

Phase III Trial of Low-level Laser Therapy to Prevent Induced Oral Mucositis in Head and Neck Cancer Patients Submitted to Concurrent Chemoradiation

Sponsor: Instituto Nacional de Cancer, Brazil

Conditions Squamous Cell Carcinoma of Hypopharynx Squamous Cell Carcinoma of Nasopharynx Squamous Cell Carcinoma of Oropharynx

Interventions Low Level Laser Therapy- (DMC, São Paulo, Brazil) Placebo (DMC, São Paulo, Brazil)

Updated 5 times since 2017 Last updated: Mar 7, 2014 Started: Jun 30, 2007 Primary completion: Jun 30, 2008 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Squamous Cell Carcinoma of Hypopharynx and Squamous Cell Carcinoma of Nasopharynx and is currently completed. Instituto Nacional de Cancer, Brazil leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Cancer, Brazil

Data source: Instituto Nacional de Cancer, Brazil

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rio de Janeiro, Brazil